According to Straits Research, “The global softgel capsules market size was valued at USD 7.55 billion in 2021. It is projected to reach USD 14.86 billion by 2030, growing at a CAGR of 7.81% during the forecast period (2022–2030).” The likelihood of an increase in demand for these capsules is accelerated by the rising number of fitness centers, marathons, and other sporting events. In addition, the market is anticipated to receive a boost from the increased interest in maintaining a healthy and active lifestyle. The availability of natural raw materials to produce vegetarian softgel capsules and a rise in demand for vegetarian softgel capsules due to their advantages and uses are driving factors in the market's expansion. A surge in innovations in the pharmaceutical industry for producing softgel capsules due to a massive pool of health-conscious consumers is anticipated to offer lucrative opportunities for market expansion during the forecast period.
Increasing Use of Technologies Creates Tremendous Opportunities
The introduction of novel products like crew caps, duo caps, and a hydrophilic sandwich (HS) that have the potential to increase the softgel capsule market in the assessment term significantly is anticipated because of the growing use of technologies by softgel capsule manufacturers. In addition, the substantial research and development efforts made by many companies will benefit the introduction of new products.
Regional Analysis
North America is the most significant in the global softgel capsules market due to the rising desire of critical companies to debut products in developed countries. The most significant players strive to receive approvals from the Food and Drug Administration (FDA) of the United States and other regulatory organizations to expand their client bases in other locations. Europe is the second-dominant region because various European countries have increased their funding for research and development of soft gelatin capsules.
Key Highlights
- Based on type, the market is segmented into gelatin/animal-based and non-animal based. The gelatin-based softgel capsules dominate the market due to the high prevalence of several chronic diseases, such as infections and cardiovascular diseases.
- Based on application, the market is segmented into antacid and anti-flatulent preparations, anti-anemic preparations, anti-inflammatory drugs, antibiotic and antibacterial drugs, cough and cold preparations, health supplements, vitamin and dietary supplements, and pregnancy. The health and dietary category are the most dominant in the market
- Based on manufacturers, the market is segmented into pharmaceutical companies, nutraceutical companies, cosmeceutical companies, contract manufacturing organizations, and softgel capsules. The pharmaceutical business segment is anticipated to expand in a lucrative manner due to the availability of softgel capsules for treating various disorders.
- North America is the most significant in the global softgel capsules market due to the rising desire of critical companies to debut products in developed countries.